Stocks / NASDAQ / Minerva Neurosciences, Inc

Minerva Neurosciences, Inc

Our Opinion

Minerva Neurosciences, Inc is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The non-human primate MPTP model used in the Primomed study is the only animal model of early Parkinson’s that replicates the progressive development of symptoms alongside progressive neurodegeneration.” Read the following article

Company Description

Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company’s product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA. [Source: MarketWatch]

Company Website: